Astellas Pharma is a Japan-based pharmaceutical company that develops, manufactures and supplies medicinal products for the healthcare industry.
Business Model:
Revenue: $10.2B
Employees: 10,001-999,999
Address: 2-5-1, Nihonbashi-Honcho
City: Tokyo
State: tōkyō prefecture
Zip: 103-8411
Country: JP
Astellas Pharma is a Japan-based pharmaceutical company that develops, manufactures and supplies medicinal products for the healthcare industry.
Contact Phone:
Contact Email:
Listed Exchange:
Tokyo Stock Exchange
IPO Date:
1/9/2009
Ticker Symbol:
4503
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
4/2012 | Telsar Pharma | Series A | 0 |
11/2021 | The National Comprehensive Cancer Network (NCCN) | Grant | - |
6/2008 | CoMentis | Series D | 0 |
10/2013 | Mitobridge | Series A | 0 |
12/2018 | Iota Biosciences | Series A | 0 |
2/2005 | FibroGen | Venture Round | 0 |
10/2019 | LabCentral | Corporate Round | 13M |
11/2017 | Catalia Health | Grant | 0 |
10/2022 | Taysha Gene Therapies | Post-IPO Equity | 50M |
11/2021 | The National Comprehensive Cancer Network (NCCN) | Grant | - |
10/2019 | LabCentral | Corporate Round | 0 |
12/2018 | Iota Biosciences | Series A | 0 |
11/2017 | Catalia Health | Grant | 0 |
10/2013 | Mitobridge | Series A | 0 |
4/2012 | Telsar Pharma | Series A | 0 |
6/2008 | CoMentis | Series D | 0 |
2/2005 | FibroGen | Venture Round | 0 |
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 7/2020 | Grant | 1 | - |
National Institute on Drug Abuse (NIDA) National Institute on Drug Abuse (NIDA) National Institute on Drug Abuse (NIDA) National Institute on Drug Abuse (NIDA) |
7/2020 | Grant | - | 7/2020 | Grant | - |
National Institute on Drug Abuse National Institute on Drug Abuse |
7/2020 | Grant | 1 | - |
National Institute on Drug Abuse (NIDA) National Institute on Drug Abuse (NIDA) National Institute on Drug Abuse (NIDA) National Institute on Drug Abuse (NIDA) |
---|
Announced Date | Name | Price |
---|---|---|
10/2020 | Iota Biosciences | |
4/2020 | Nanna Therapeutics | |
12/2019 | Xyphos Biosciences | |
12/2019 | Audentes Therapeutics | |
12/2018 | Potenza Therapeutics | |
8/2018 | Quethera | |
2/2018 | Universal Cells Inc. | |
12/2017 | Mitobridge | |
4/2017 | Ogeda | |
10/2016 | Ganymed Pharmaceuticals |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|